Master Protocols for Drug and Biological Product Development; Draft Guidance for Industry; Availability

NonrulemakingNoticeFDA_FRDOC_0001-14301
Comments
0
Awaiting comments
Deadline
61 days
Closes Aug 25, 2026
Net supportiSupport minus oppose · campaigns included
Document

Details

The document's own metadata, straight from regulations.gov.

Posted
Jun 24, 2026
Comment period
Jun 24, 2026 – Aug 25, 2026
Agency
Food and Drug Administration (FDA)
FR Doc
2026-12620
Analysis

Overview

No comments yet — comment period open · 61 days left.

Comments

Explorer

Every mirrored comment — filter by stance, campaign, or issue.

Filter:

No comments match.